CASP8 and neoplasm: A licensed and commercially available anticancer agent, trabectedin (Yondelis®), induced apoptosis in mononuclear phagocytes (TAMs, monocytes), in a caspase-8 dependent manner, leading to less tumor growth and angiogenesis [136,137] (Table 2).